TICTRAC LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  -20%

  £6,326,471 → £5,058,050

• Cash

  +160.5%

  £209,803 → £546,487

• Net assets

  +196.8%

  £1,779,862 → £5,282,607

  highest in 5 filed years

• Employees

  -50%

  16 → 8

  lowest in 5 filed years

• Operating profit

  -10.9%

  £4,124,988 → £3,674,084

• Profit before tax

  -13.2%

  £4,033,963 → £3,501,063

• Wages

  -56.7%

  £1,623,299 → £703,243

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Grant Thornton UK LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The company made a profit before tax for the year ended 31 December 2024 of £3,501,063 (2023: profit of £4,033,963) with cash of £546,487 (2023: £209,803) at the year end. Dialogue Health Technologies Inc. ("the immediate parent") is the immediate parent company of Tictrac Limited and has issued a letter of financial support to Tictrac Limited for the 12 months after the approval of the financial statements. The immediate parent, Dialogue Health Technologies Inc, has confirmed that it will continue to financially support the company for at least 12 months, from the date of approval of the statutory financial statements for the year ended 31 December 2024 to enable it to meet its liabilities as they fall due. The company has demonstrated its ability to meet all of its obligations at the Statement of Financial Position date, even without considering the receivable from Dialogue Health Technologies Inc. By including the receivable from Dialogue Health Technologies Inc, the company gains additional resources that will allow it to operate for the next 12 months. Additionally, the immediate parent has confirmed its capacity to provide financial support if required. This assurance takes into account potential scenarios where the company might face financial difficulties and require additional funding to continue operations. Therefore, the directors continue to adopt the going concern basis of preparation.”

Significant events

• “There have been no significant events affecting the company since the reporting date.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

7

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.